Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
7.29
+0.23 (3.26%)
At close: Apr 17, 2026, 4:00 PM EDT
7.15
-0.14 (-1.92%)
After-hours: Apr 17, 2026, 4:24 PM EDT
Aura Biosciences Market Cap
Aura Biosciences has a market cap or net worth of $467.66 million as of April 17, 2026. Its market cap has increased by 56.75% in one year.
Market Cap
467.66M
Enterprise Value
340.79M
1-Year Change
56.75%
Ranking
Category
Stock Price
$7.29
Market Cap Chart
Since the IPO on October 29, 2021, Aura Biosciences's market cap has increased from $397.73M to $467.66M, an increase of 17.58%. That is a compound annual growth rate of 3.69%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 467.66M | 35.12% |
| Dec 31, 2025 | 346.09M | -15.71% |
| Dec 31, 2024 | 410.60M | -5.92% |
| Dec 29, 2023 | 436.44M | 12.22% |
| Dec 30, 2022 | 388.92M | -21.59% |
| Dec 31, 2021 | 496.00M | 24.71% |
| Oct 29, 2021 | 397.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Invivyd | 492.08M |
| REGENXBIO | 489.85M |
| Benitec Biopharma | 482.31M |
| XOMA Royalty | 474.37M |
| vTv Therapeutics | 473.05M |
| Ginkgo Bioworks Holdings | 467.40M |
| Century Therapeutics | 467.28M |
| Candel Therapeutics | 466.58M |